All Sections
Welcome guest, you have 3 views left. | Register | Sign In

NH Angle is a news and information aggregation by staff and audience of the New Hampshire Union Leader, The Goffstown News, The Bedford Bulletin, The Hooksett Banner and The Salem Observer. Share a news link here or comment on this item below.

Dartmouth prof’s biomed firm follows a more entrepreneurial path for its anti-cancer discovery

Officially launched in 2011, ImmuNext has already landed what could potentially be a $150 million deal with Johnson & Johnson that takes the company’s cancer-fighting technology from lab to fruition


Post a comment

You must sign in before you can post comments. If you are experiencing issues with your account please e-mail

Most Popular

Follow us on Twitter Follow us on Facebook Follow our RSS feed
Union Leader app for Apple iPad or Android *
Click to download from Apple Apps StoreClick to download from Android Marketplace
* e-Edition subscription required